Rappel de TriForce Peripheral Crossing Set(intended to be percutaneously introduced into blood vessels and support a wire guide while performing percutaneous peripheral interventions)

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par William A Cook Australia Pty Ltd.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    RC-2017-RN-00362-1
  • Classe de risque de l'événement
    Class I
  • Date de mise en oeuvre de l'événement
    2017-03-10
  • Pays de l'événement
  • Source de l'événement
    DHTGA
  • URL de la source de l'événement
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    There has been an increase in reports of blood loss associated with devices using a specific haemostatic valve design (referred to as the “blue” valve or polyisoprene valve). in november 2015, products manufactured with the haemostatic blue valve design were either made obsolete or changed to incorporate a different valve design with improved haemostasis. cook has continued to receive reports of blood loss associated with the earlier generation products containing the “blue” valve and therefore has initiated this action on those devices. potential adverse events that may occur if these devices are used in the arterial system include delay in procedure and blood loss. if devices are used in the central venous system, adverse events that may occur include delay in procedure, blood loss, or air embolism.
  • Action
    Customers are notified to quarantine and immediately return any affected product that remains unused to Cook Medical.

Device

  • Modèle / numéro de série
    TriForce Peripheral Crossing Set(intended to be percutaneously introduced into blood vessels and support a wire guide while performing percutaneous peripheral interventions)Catalogue Identified (Prefix/Suffix): KCXS-5.0- / -RB-0/0-HCKCXS-5.0- / -RB-0/DAV-HCKCXS-5.0- / -RB-MPB/0-HCKCXS-5.0- / -RB-MPB/DAV-HCAffected Lot Numbers: 6446148, 6446178, 6446172, 6446175, 6446166, 6446157, 6458182, 6446154ARTG Number: 246412
  • Classification du dispositif
  • Manufacturer

Manufacturer